Multicenter Prospective Registry to Evaluate Use and Outcomes of NanoBone® Bone Graft Substitute in Acute Trauma Patients
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.
• Subjects at least 18 years old at the time of injury
• Acute fractures, resulting from blunt or penetrating trauma
‣ In the extremities or pelvis
⁃ Requiring surgery
⁃ Treated emergently, delayed or staged up to 4 weeks from the date of injury
⁃ Where bone grafting is clinically indicated